An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers.
Saved in:
| Title: | An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers. |
|---|---|
| Authors: | Shin, Seol Hwa1,2,3, Park, Yun‐Hee4, Park, Seok Soon2,3, Ju, Eun Jin2,3, Park, Jin1,2,3, Ko, Eun Jung2,3, Bae, Dong Jun2, Kim, Sang‐Yeob2,5, Chung, Chul‐Woong4, Song, Ho Young4, Jang, Se Jin1,6, Jeong, Seong‐Yun1,2,3,5, syj@amc.seoul.kr, Song, Si Yeol3,7, coocoori@amc.seoul.kr, Choi, Eun Kyung1,3,7, ekchoi@amc.seoul.kr |
| Source: | Advanced Science; 12/8/2021, Vol. 8 Issue 23, p1-15, 15p |
| Database: | Applied Science & Technology Source |
| ISSN: | 21983844 |
|---|---|
| DOI: | 10.1002/advs.202102414 |
